Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Recent Advances in Pulmonary Hypertension
Author(s): Akshyaya Pradhan , Richa Tyagi , Prachi Sharma , et al Added: 1 year ago

Prevention & Chronic Conditions
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease
Author(s): William Herrington Added: 1 year ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Updates on Chronic Coronary Syndrome
Author(s): Filippo Gurgoglione , Giampaolo Niccoli Added: 1 year ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Anticoagulation in Cardio-oncology
Author(s): Sebastian Szmit , Maciej Krzakowski , Dariusz M Kowalski , et al Added: 1 month ago

Anticoagulation

CV Disease in Special Populations
30th Annual Meeting of the ISCP
Author(s): Inés Martínez-Salgado , Manuel Sánchez , Diego De la Eranueva Calvo , et al Added: 3 weeks ago

Prevention & Chronic Conditions

Heart Failure
30th Annual Meeting of the ISCP
Author(s): Diego Manuel de la Eranueva , Ignacio Quevedo , Adela Castro Garcia , et al Added: 3 weeks ago

Prevention & Chronic Conditions

Heart Failure
ACC 25 Late-Breaking Discussion: The ADVANCE-HTN Trial
Author(s): Harriette Van Spall , Luke Laffin Added: 1 year ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial… View more

Prevention & Chronic Conditions
ESC 25: ESVM Guidelines on Interventional Treatment of VTE
Author(s): Oliver Schlager Added: 8 months ago
ESC Congress 2025 - New guidelines for catheter-based VTE therapy emphasise the importance of involving vascular experts, and performing procedures in experienced centers.Dr Oliver Schlager (Medical University of Vienna, AT) joins us to discuss the newly released 2025 ESVM Guidelines on Interventional Treatment of Venous Thromboembolism, endorsed by European national societies of Vascular… View more

Guidelines & Statements

Intervention
Pulmonary Embolism Management
Author(s): Andrew SP Sharp, Mantas Buitkus, Gilles Lemesle Start date: Oct 07, 2025
Pulmonary Embolism (PE) remains a leading cause of cardiovascular morbidity and mortality, requiring timely intervention and coordinated multidisciplinary care. This session will provide an in-depth analysis of the current PE treatment landscape, including the latest clinical trial updates (HI-PEITHO, PEERLESS), institutional decision-making workflows and collaborative patient management… View more

Intervention

Vascular Disease and Surgery
Job title: Associate Professor of Cardiovascular Surgery
Dr Mert Dumantepe is an Associate Professor of Cardiovascular Surgery at Acibadem University School of Medicine, Turkey. He completed his graduation from Istanbul University School of Medicine, Turkey in 2001. He did a fellowship in chronic thromboembolic pulmonary hypertension and pulmonary endarterectomy and the heart transplantation and mechanical asist device programme at the University of… View more